Aldeyra Therapeutics, Inc. ALDX
NASDAQ · United States · Health Technology
$1.17-0.12 (-9.30%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -0.09 | -0.08 | -16.1% | $0 | — | -3.1%$1.60→$1.55 |
| Q1 2026 | 2026-05-07 | -0.06 | -0.13 | +53.8% | — | — | -0.6%$1.74→$1.73 |
| Q4 2025 | 2026-02-27 | -0.10 | -0.14 | +28.6% | — | — | +2.2%$5.50→$5.62 |
| Q3 2025 | 2025-11-05 | -0.13 | -0.17 | +23.5% | — | — | -2.2%$4.92→$4.81 |
| Q1 2025 | 2025-05-14 | -0.17 | -0.28 | +39.3% | — | — | — |
| Q4 2024 | 2025-02-28 | -0.27 | -0.22 | -22.7% | — | — | — |
| Q2 2024 | 2024-08-01 | -0.28 | -0.14 | -100.0% | — | — | — |
| Q1 2024 | 2024-05-02 | -0.14 | -0.11 | -27.3% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.